|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/22 | (2006.01) |
| (11) | Number of the document | 1850873 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06734583.5 |
| Date of filing the European patent application | 2006-02-08 | |
| (97) | Date of publication of the European application | 2007-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation | 2019-04-10 |
| (86) | Number | PCT/US2006/004424 |
| Date | 2006-02-08 |
| (87) | Number | WO 2006/086469 |
| Date | 2006-08-17 |
| (30) | Number | Date | Country code |
| 651343 P | 2005-02-08 | US |
| (72) |
LEDBETTER, Steven R., US
HART, Celia P., FR
HOLGATE, Robert G., GB
JERMUTUS, Lutz U., GB
BUCHANAN, Catriona L., GB
DUNCAN, Alexander R., GB
FINCH, Donna K., GB
|
| (73) |
Genzyme Corporation,
50 Binney Street, Cambridge, MA 02142,
US
Optein, Inc., Corporation Service Company 2711 Centerville Road Suite 400, Wilmington, DE 19808, US |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Antikūnas prieš TGF beta |
| ANTIBODIES TO TGFBETA |
| Payment date | Validity (years) | Amount | |
| 2024-12-20 | 347.00 EUR |